Powder: -20°C for 3 years | In solvent: -80°C for 1 year
Compound C108 is an inhibitor of GTPase-activating protein SH3 domain-binding protein 2 (G3BP2). Compound C108 can be used in studies about breast tumors and esophageal squamous cell carcinoma.
Pack Size | Availability | Price/USD | Quantity |
---|---|---|---|
1 mg | In stock | $ 38.00 | |
5 mg | In stock | $ 82.00 | |
10 mg | In stock | $ 132.00 | |
25 mg | In stock | $ 265.00 | |
50 mg | In stock | $ 423.00 | |
100 mg | In stock | $ 628.00 | |
500 mg | In stock | $ 1,350.00 | |
1 mL * 10 mM (in DMSO) | In stock | $ 127.00 |
Description | Compound C108 is an inhibitor of GTPase-activating protein SH3 domain-binding protein 2 (G3BP2). Compound C108 can be used in studies about breast tumors and esophageal squamous cell carcinoma. |
In vitro | In BT474 cells, Compound C108 (1 μM) shows anti-tumor activity[1]. In G3BP2 overexpressing KYSE410 cells and LINC01554 transfected KYSE30 cells, Compound C108 (4 μM) reduces the protein expression of G3BP2 and attenuates ESCC cell metastasis, migration and invasion[2]. |
In vivo | In a mouse xenograft model of breast cancer, compound C108 (1 μM) reduces the proportion of tumor-initiating cells approximately 10-fold[1]. |
Molecular Weight | 270.28 |
Formula | C15H14N2O3 |
CAS No. | 15533-09-2 |
Powder: -20°C for 3 years | In solvent: -80°C for 1 year
DMF:PBS(pH 7.2)(1:6): 0.14 mg/mL
DMF: 1 mg/mL
DMSO: 22.5 mg/mL (83.2 mM), Sonification is recommended.
You can also refer to dose conversion for different animals. More
bottom
Please see Inhibitor Handling Instructions for more frequently ask questions. Topics include: how to prepare stock solutions, how to store products, and cautions on cell-based assays & animal experiments, etc.
Compound C108 15533-09-2 GPCR/G Protein GTPase Compound C-108 Compound C 108 inhibitor inhibit